Pre-Market Top Loser: GNCA Genocea Biosciences (NASDAQ) 13 Feb 2026: liquidity flag

GNCA stock opened the pre-market session on 13 Feb 2026 at USD 0.0001, down about 97.44% from the prior close. This sharp fall places Genocea Biosciences, Inc. (GNCA) among pre-market top losers on the NASDAQ in the United States. Volume was light at 30,268 shares versus a 50-day average of 80,568. Investors should note the stock’s near-zero market cap reading and Chapter 11 history as key drivers of extreme volatility.